Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 4 | $194,885 |
| Sells | 56 | $700,738 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 20 Nov 2024 18:05 | ATRA | Atara Biotherapeutics Inc | HENRICH JILL | EVP, Chief Regulatory Officer | 18 Nov 2024 | Sale | 1,000 | 11.198 | 11,198 | D |
| 20 Nov 2024 18:04 | ATRA | Atara Biotherapeutics Inc | HYLLENGREN ERIC J | EVP, CFO and COO | 18 Nov 2024 | Sale | 1,364 | 11.198 | 15,274 | D |
| 20 Nov 2024 18:04 | ATRA | Atara Biotherapeutics Inc | NGUYEN ANHCO | President and CEO | 18 Nov 2024 | Sale | 1,664 | 11.198 | 18,633 | D |
| 20 Aug 2024 18:27 | ATRA | Atara Biotherapeutics Inc | TOUCHON PASCAL | President and CEO | 16 Aug 2024 | Sale | 276 | 6.63 | 1,830 | D |
| 20 Aug 2024 18:27 | ATRA | Atara Biotherapeutics Inc | TOUCHON PASCAL | President and CEO | 16 Aug 2024 | Sale | 2,762 | 6.629 | 18,309 | D |
| 20 Aug 2024 18:27 | ATRA | Atara Biotherapeutics Inc | NGUYEN ANHCO | EVP, Chief Sci. & Tech Officer | 16 Aug 2024 | Sale | 56 | 6.631 | 371 | D |
| 20 Aug 2024 18:27 | ATRA | Atara Biotherapeutics Inc | NGUYEN ANHCO | EVP, Chief Sci. & Tech Officer | 16 Aug 2024 | Sale | 1,468 | 6.629 | 9,731 | D |
| 20 Aug 2024 18:27 | ATRA | Atara Biotherapeutics Inc | NGUYEN ANHCO | EVP, Chief Sci. & Tech Officer | 16 Aug 2024 | Sale | 297 | 6.63 | 1,969 | D |
| 20 Aug 2024 18:27 | ATRA | Atara Biotherapeutics Inc | MURUGAN AMAR | EVP, Chief Legal Officer | 16 Aug 2024 | Sale | 89 | 6.631 | 590 | D |
| 20 Aug 2024 18:27 | ATRA | Atara Biotherapeutics Inc | MURUGAN AMAR | EVP, Chief Legal Officer | 16 Aug 2024 | Sale | 192 | 6.63 | 1,273 | D |
| 20 Aug 2024 18:27 | ATRA | Atara Biotherapeutics Inc | MURUGAN AMAR | EVP, Chief Legal Officer | 16 Aug 2024 | Sale | 877 | 6.629 | 5,814 | D |
| 20 Aug 2024 18:27 | ATRA | Atara Biotherapeutics Inc | HYLLENGREN ERIC J | EVP, CFO | 16 Aug 2024 | Sale | 29 | 6.631 | 192 | D |
| 20 Aug 2024 18:27 | ATRA | Atara Biotherapeutics Inc | HYLLENGREN ERIC J | EVP, CFO | 16 Aug 2024 | Sale | 1,041 | 6.629 | 6,901 | D |
| 20 Aug 2024 18:26 | ATRA | Atara Biotherapeutics Inc | HENRICH JILL | EVP, Global Head RA & Quality | 16 Aug 2024 | Sale | 132 | 6.631 | 875 | D |
| 20 Aug 2024 18:26 | ATRA | Atara Biotherapeutics Inc | HENRICH JILL | EVP, Global Head RA & Quality | 16 Aug 2024 | Sale | 831 | 6.629 | 5,509 | D |
| 20 May 2024 20:34 | ATRA | Atara Biotherapeutics Inc | TOUCHON PASCAL | President and CEO | 16 May 2024 | Sale | 81,506 | 0.617 | 50,289 | D |
| 20 May 2024 20:34 | ATRA | Atara Biotherapeutics Inc | NGUYEN ANHCO | EVP, Chief Sci. & Tech Officer | 16 May 2024 | Sale | 42,899 | 0.617 | 26,469 | D |
| 20 May 2024 20:33 | ATRA | Atara Biotherapeutics Inc | MURUGAN AMAR | EVP, Chief Legal Officer | 16 May 2024 | Sale | 32,401 | 0.617 | 19,991 | D |
| 20 May 2024 20:33 | ATRA | Atara Biotherapeutics Inc | HYLLENGREN ERIC J | EVP, CFO | 16 May 2024 | Sale | 28,648 | 0.617 | 17,676 | D |
| 20 May 2024 20:32 | ATRA | Atara Biotherapeutics Inc | HENRICH JILL | EVP, Global Head RA & Quality | 16 May 2024 | Sale | 25,750 | 0.617 | 15,888 | D |
| 06 Mar 2024 18:19 | ATRA | Atara Biotherapeutics Inc | TOUCHON PASCAL | President and CEO | 04 Mar 2024 | Sale | 24,844 | 0.72 | 17,888 | D |
| 06 Mar 2024 18:18 | ATRA | Atara Biotherapeutics Inc | NGUYEN ANHCO | EVP, Chief Sci. & Tech Officer | 04 Mar 2024 | Sale | 10,746 | 0.72 | 7,737 | D |
| 06 Mar 2024 18:18 | ATRA | Atara Biotherapeutics Inc | MURUGAN AMAR | EVP, Chief Legal Officer | 04 Mar 2024 | Sale | 10,044 | 0.72 | 7,232 | D |
| 06 Mar 2024 18:17 | ATRA | Atara Biotherapeutics Inc | HYLLENGREN ERIC J | EVP, CFO | 04 Mar 2024 | Sale | 5,217 | 0.72 | 3,756 | D |
| 06 Mar 2024 18:17 | ATRA | Atara Biotherapeutics Inc | HYLLENGREN ERIC J | EVP, CFO | 04 Mar 2024 | Sale | 1,462 | 0.721 | 1,054 | D |
| 06 Mar 2024 18:16 | ATRA | Atara Biotherapeutics Inc | HENRICH JILL | EVP, Global Head RA & Quality | 04 Mar 2024 | Sale | 3,879 | 0.72 | 2,793 | D |
| 20 Nov 2023 17:31 | ATRA | Atara Biotherapeutics Inc | TOUCHON PASCAL | President and CEO | 16 Nov 2023 | Sale | 20,409 | 0.389 | 7,939 | D |
| 20 Nov 2023 17:31 | ATRA | Atara Biotherapeutics Inc | NGUYEN ANHCO | EVP, Chief Sci. & Tech Officer | 16 Nov 2023 | Sale | 8,856 | 0.389 | 3,445 | D |
| 20 Nov 2023 17:30 | ATRA | Atara Biotherapeutics Inc | MURUGAN AMAR | EVP, Chief Legal Officer | 16 Nov 2023 | Sale | 8,307 | 0.389 | 3,231 | D |
| 20 Nov 2023 17:30 | ATRA | Atara Biotherapeutics Inc | JOSHI MANHER | EVP, Chief Medical Officer | 16 Nov 2023 | Sale | 12,287 | 0.389 | 4,780 | D |
| 20 Nov 2023 17:29 | ATRA | Atara Biotherapeutics Inc | HYLLENGREN ERIC J | SVP, CFO | 16 Nov 2023 | Sale | 11,958 | 0.389 | 4,652 | D |
| 20 Nov 2023 17:29 | ATRA | Atara Biotherapeutics Inc | HENRICH JILL | EVP, Global Head RA & Quality | 16 Nov 2023 | Sale | 3,267 | 0.389 | 1,271 | D |
| 15 Nov 2023 17:07 | ATRA | Atara Biotherapeutics Inc | GALLAGHER CAROL GILTNER | Director | 14 Nov 2023 | Purchase | 90,980 | 0.3098 | 28,186 | D |
| 15 Nov 2023 17:07 | ATRA | Atara Biotherapeutics Inc | GALLAGHER CAROL GILTNER | Director | 13 Nov 2023 | Purchase | 179,020 | 0.2236 | 40,029 | D |
| 14 Nov 2023 18:29 | ATRA | Atara Biotherapeutics Inc | HEIDEN WILLIAM K | Director | 10 Nov 2023 | Purchase | 100,000 | 0.2533 | 25,330 | D |
| 14 Nov 2023 18:27 | ATRA | Atara Biotherapeutics Inc | DOBMEIER ERIC | Director | 10 Nov 2023 | Purchase | 446,825 | 0.2268 | 101,340 | D |
| 18 Aug 2023 18:25 | ATRA | Atara Biotherapeutics Inc | HYLLENGREN ERIC J | SVP, CFO | 16 Aug 2023 | Sale | 1,778 | 1.654 | 2,941 | D |
| 18 Aug 2023 18:25 | ATRA | Atara Biotherapeutics Inc | HYLLENGREN ERIC J | SVP, CFO | 16 Aug 2023 | Sale | 6,408 | 1.652 | 10,586 | D |
| 18 Aug 2023 18:25 | ATRA | Atara Biotherapeutics Inc | MURUGAN AMAR | EVP, Chief Legal Officer | 16 Aug 2023 | Sale | 3,622 | 1.653 | 5,987 | D |
| 18 Aug 2023 18:25 | ATRA | Atara Biotherapeutics Inc | MURUGAN AMAR | EVP, Chief Legal Officer | 16 Aug 2023 | Sale | 5,050 | 1.652 | 8,343 | D |
| 18 Aug 2023 18:25 | ATRA | Atara Biotherapeutics Inc | TOUCHON PASCAL | President and CEO | 16 Aug 2023 | Sale | 9,334 | 1.653 | 15,429 | D |
| 18 Aug 2023 18:25 | ATRA | Atara Biotherapeutics Inc | TOUCHON PASCAL | President and CEO | 16 Aug 2023 | Sale | 21,432 | 1.652 | 35,406 | D |
| 18 Aug 2023 18:25 | ATRA | Atara Biotherapeutics Inc | NGUYEN ANHCO | EVP, Chief Sci. & Tech Officer | 16 Aug 2023 | Sale | 5,849 | 1.652 | 9,663 | D |
| 18 Aug 2023 18:25 | ATRA | Atara Biotherapeutics Inc | NGUYEN ANHCO | EVP, Chief Sci. & Tech Officer | 16 Aug 2023 | Sale | 9,277 | 1.653 | 15,335 | D |
| 18 Aug 2023 18:25 | ATRA | Atara Biotherapeutics Inc | JOSHI MANHER | EVP, Chief Medical Officer | 16 Aug 2023 | Sale | 3,773 | 1.653 | 6,237 | D |
| 18 Aug 2023 18:25 | ATRA | Atara Biotherapeutics Inc | JOSHI MANHER | EVP, Chief Medical Officer | 16 Aug 2023 | Sale | 3,202 | 1.652 | 5,290 | D |
| 18 Aug 2023 18:25 | ATRA | Atara Biotherapeutics Inc | HENRICH JILL | EVP, Global Head RA & Quality | 16 Aug 2023 | Sale | 558 | 1.654 | 923 | D |
| 18 Aug 2023 18:25 | ATRA | Atara Biotherapeutics Inc | HENRICH JILL | EVP, Global Head RA & Quality | 16 Aug 2023 | Sale | 2,788 | 1.653 | 4,609 | D |
| 29 Jun 2023 16:15 | ATRA | Atara Biotherapeutics Inc | TOUCHON PASCAL | President and CEO | 27 Jun 2023 | Sale | 14,291 | 1.66 | 23,723 | D |
| 18 May 2023 20:17 | ATRA | Atara Biotherapeutics Inc | MURUGAN AMAR | EVP, Chief Legal Officer | 16 May 2023 | Sale | 985 | 2.038 | 2,007 | D |
| 18 May 2023 20:17 | ATRA | Atara Biotherapeutics Inc | MURUGAN AMAR | EVP, Chief Legal Officer | 16 May 2023 | Sale | 7,404 | 2.037 | 15,082 | D |
| 18 May 2023 20:17 | ATRA | Atara Biotherapeutics Inc | TOUCHON PASCAL | President and CEO | 16 May 2023 | Sale | 29,766 | 2.037 | 60,633 | D |
| 18 May 2023 20:17 | ATRA | Atara Biotherapeutics Inc | BANARD CHARLENE A. | EVP, Chief Technical Officer | 16 May 2023 | Sale | 19,040 | 2.037 | 38,784 | D |
| 18 May 2023 20:17 | ATRA | Atara Biotherapeutics Inc | HYLLENGREN ERIC J | SVP, CFO | 16 May 2023 | Sale | 1,719 | 2.038 | 3,503 | D |
| 18 May 2023 20:17 | ATRA | Atara Biotherapeutics Inc | HYLLENGREN ERIC J | SVP, CFO | 16 May 2023 | Sale | 6,199 | 2.037 | 12,627 | D |
| 06 Mar 2023 18:49 | ATRA | Atara Biotherapeutics Inc | TOUCHON PASCAL | President and CEO | 02 Mar 2023 | Sale | 15,679 | 3.627 | 56,868 | D |
| 06 Mar 2023 18:48 | ATRA | Atara Biotherapeutics Inc | MURUGAN AMAR | SVP, GC & Secretary | 02 Mar 2023 | Sale | 4,221 | 3.627 | 15,310 | D |
| 06 Mar 2023 18:47 | ATRA | Atara Biotherapeutics Inc | KOPPIKAR UTPAL | Chief Financial Officer | 02 Mar 2023 | Sale | 6,871 | 3.627 | 24,921 | D |
| 06 Mar 2023 18:46 | ATRA | Atara Biotherapeutics Inc | DUPONT JAKOB | EVP, Head of R&D | 02 Mar 2023 | Sale | 5,074 | 3.627 | 18,403 | D |
| 09 Feb 2023 17:00 | ATRA | Atara Biotherapeutics Inc | KOPPIKAR UTPAL | Chief Financial Officer | 07 Feb 2023 | Sale | 2,485 | 5.46 | 13,568 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)